Tucson, Ariz. – Protein Technologies, Inc., a leader in the field of peptide synthesis instrumentation and reagents, today introduced Prelude X, the first peptide synthesizer featuring rapid and uniform induction heat across six reaction vessels. This unique attribute enables researchers to synthesize peptides that require heat-induced reactions with maximum efficiency, purity and yield.

Pharmaceutical and biotechnology companies are increasingly investing in the development of peptide therapeutics that provide patients suffering from cancer, metabolic diseases and other illnesses with highly-targeted therapies and minimal side effects. To develop commercially viable therapies, scientists are exploring complex modified molecules, such as cyclic and stapled synthetic peptides that provide improved bioavailability and stability. Prelude X is designed to improve research efforts focused on unveiling the potential of complex peptide molecules.

“Protein Technologies is dedicated to providing robust, high-quality products that support innovative research efforts driving the discovery of novel therapeutics,” said Nate Cosper, Ph.D., President and CEO of Protein Technologies, Inc. “With a unique combination of capabilities—rapid induction heating, oscillation mixing and UV monitoring—Prelude X synthesizes difficult peptides with exceptional purity and reduced solvent consumption, thereby accelerating timelines for optimized lead candidates. Prelude X exemplifies our commitment to customer-guided innovation and to addressing the needs of the peptide research community.”

In addition to parallel heating Prelude X features oscillation mixing and UV monitoring, creating a synthesis system that meets the evolving needs of a research community that demands speed, efficiency and quality. The IntelliSynth® UV monitoring capability creates the opportunity for real-time observation of key reactions during the solid phase peptide cycle. Access to this knowledge provides precise assessment of reaction completion and automated control of the synthesis process, thus reducing reaction time and minimizing reagent consumption. For many reactions, heating is the critical element to improving efficiency. The Prelude X’s oscillation mixing supports nitrogen bubbling and variable speed shaking, enabling precise and controlled heat application throughout a reaction mixture. Prelude X also offers pre-activation capabilities to further increase yields and prime-free Single-Shot™ delivery that saves expensive reagents and reduces waste.

Prelude X is currently on display at the American Peptide Symposium in Orlando, Florida. Researchers are invited to visit the Protein Technologies booth (#27-30) to experience Prelude X and other offerings from Protein Technologies.

For additional information, please visit www.ptipep.com or call 1-800-477-6834.

About Protein Technologies, Inc.

Founded in 1985, Protein Technologies, Inc. provides quality peptide synthesizers and reagents to academic and commercial researchers at leading universities, biotechnology, and pharmaceutical companies. Based in Tucson, Arizona, Protein Technologies is committed to delivering quality products and uncompromised customer service built on reliability and trust. As market demand for peptide therapeutics increases, Protein Technologies continues to evolve to consistently deliver innovative technologies that improve the efficiency of drug discovery. To learn more about Protein Technologies, please visit www.ptipep.com.